drugset / Trial / NCT01832129
Vitamin B12 Acceptance and Biomarker Response Study
Phase 4
Completed
37 enrolled
University Hospital, Basel, Switzerland
Aarelab AG · collabUniversity of Basel · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
In this study, biomarker response after supplementation with oral and intramuscular vitamin B12 will be compared in a randomized clinical trial. Electronic compliance monitoring will be used to control for non compliance as a possible confounder in oral treatment. Additionally subjective acceptance in terms of presumed preferences will be compared with oral vs. intramuscular supplementation of vitamin B12 in the view of the patient.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydroxocobalamin | Unknown | 1 mg | Intramuscular |
| Subject | Vitamin B12 | Other / unclassified | 1 mg | Oral |